Novartis said Monday that Xolair (ingredient: omalizumab) received the approval of the Ministry of Food and Drug Safety to treat chronic rhinosinusitis with nasal polyps not properly regulated by nasal corticosteroids in people over 18.The expanded indication is based on global phase 3 POLYP1 and PO
EuBiologics said Monday that it has signed a letter of intent (LOI) with Glovax Biotech of the Philippines to transfer technology on developing Covid-19 vaccine, EuCorVac-19.If the two companies make a formal agreement, EuBiologics will transfer technology related to antigen production, manufacturin
Overheated competition for the production of Russian Covid-19 vaccine Sputnik V has led to an internal dispute of a Korean consortium. Currently, two consortia of more than 10 Korean companies are planning to manufacture Sputnik V.On Monday, GL Rapha and its subsidiary Hankook Korus announced that t
Sanofi Pasteur said Monday that it has launched Korea's first hexavalent vaccine, Hexaxim.The vaccine is a combo vaccine in a complete liquid formulation containing hepatitis B antigen developed by Sanofi Pasteur. Hexaxim provides vaccination for six infectious diseases -- pentavalent vaccine-diphth
The emergence of affordable Chinese immune checkpoint inhibitors (ICIs) is drawing attention to whether they will change the landscape of the global pharmaceutical market.GlobalData, a U.K. data analytics and consulting firm, said on Friday that Chinese ICIs for various indications are getting ready
Contract manufacturing organization (CMO) business has become a mainstream strategy for the local pharmaceutical and biotech industry. It is noteworthy that CMO biz is no longer regarded as a short-term trend but a long-term growth engine for pharmaceutical companies.Biopharmaceutical CMOs take orde
Two consortia of Korean pharmaceutical companies said Friday they have agreed to make more than a billion doses of the Sputnik V Covid-19 vaccine developed by Russia's Gamaleya Research Institute of Epidemiology and Microbiology.A consortium formed by Hankook Korus, which includes GL Rapha, Chong Ku
Chong Kun Dang said it received approval to conduct phase 3 clinical trials of its investigational Covid-19 treatment, Nafabeltan (ingredient: nafamostat mesylate), from the Ministry of Food and Drug Safety on Thursday.The company said the approval would help it speed up the development of the Covid
Nebilet (ingredient: nebivolol hydrochloride), a third-generation beta-blocker for hypertension developed by Menarini, proved efficacy in Korean hypertensive patients in the sub-group analysis of the real-world BENEFIT study, the company said.Menarini presented the sub-group analysis results in a po
Sanofi-Aventis Korea said Friday that Dupixent (ingredient: dupilumab) improved nasal congestion and obstruction by 51 percent compared to baseline and showed three times higher efficacy than the placebo group.“Chronic rhinosinusitis with nasal polyps has a high probability of recurrence even after
Huons Biopharma said that it has signed a license-out agreement with Aquavit Holdings, a U.S. pharmaceutical company, to export Hutox, its botulinum toxin (BTX) product, over 10 years.Under the accord, Aquavit will be responsible for local clinical trials, licensing, marketing, and sales. At the sam
MedPacto, a biomarker-based developer of innovative new drugs, said Wednesday that it has signed an agreement with Samsung Biologics to develop and manufacture MA-B2, an antibody treatment targeting BAG2.Through the contract development and manufacturing organization (CDMO) deal, MedPacto aims to co
The annual salary of executives and employees working at multinational pharmaceutical companies’ Korean offshoots reached 91 million won ($81,614) on average last year.According to the Financial Supervisory Service, the average wage is based on a survey of 5,156 executives and employees working at 2
Korean pharmaceutical and biotech companies are racing to develop Covid-19 treatments and vaccines using RNA technology.GC Wellbeing is repurposing Laennec, a human placenta hydrolysate injection, as an antiviral drug against Covid-19.The company said it began to analyze the microRNA(miRNA) of Laenn
Hugel, a medical aesthetics company, said Thursday that it has established Hugel Shanghai Aesthetics to speed up its advance to the Chinese market.Hugel obtained product licenses for Letybo 50 Unit, its botulinum toxin (BTX) product, in February, following the approval of Letybo 100 Unit in October
Sillajen said Wednesday that it selected M2N as the preferred negotiator to acquire the company, raising expectations about resuming normal operations.The company narrowly avoided delisting last year after the Korea Exchange (KRX) gave the company a one-year grace period to improve management transp
PharmAbcine said Monday that its cancer drug candidate, PMC-309, has promoted T cell activity and inhibited VISTA interaction in vitro test, showing an improved therapeutic effect when combined with existing anticancer therapy.At the poster session of the American Association for Cancer Research's a
Tislelizumab, an anti-programmed death-1(PD-1) immunotherapy developed by Chinese drugmaker BeiGene, is challenging to enter the global market. Swiss pharmaceutical firm Novartis recently licensed in the global sales right of tislelizumab.BeiGene disclosed the results of the global phase-3 Rationale
Veterinary clinics used human medicines instead of veterinary drugs last year, a pharmacists’ group said.On Tuesday, the Korean Pharmaceutical Association said a study on improving the management system for human drugs used in animals, conducted from August 2020 to November 2020, showed that 65 out
JW Pharmaceutical said Tuesday that it has confirmed its anticancer candidate, JW-2286, inhibits STAT3 (signal transducer and activator of transcription 3) and potently impairs the growth and survival of triple-negative breast cancer (TNBC).At the American Association for Cancer Research's annual me